Latest Disc Medicine News & Updates
See the latest news and media coverage for Disc Medicine. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company developing hematology treatments
discmedicine.com- Headquarters
- Watertown, United States
- Company type
- Public company
- Number of employees
- 150–200
Latest news about Disc Medicine
Company announcements
-
Disc Medicine announces oral presentation of RALLY-MF Phase 2 data
Data from DISC-0974 trial in myelofibrosis patients with anemia will be presented at ASCO Annual Meeting on June 2, 2026.
-
Disc Medicine completes randomization in APOLLO trial
The last participant is dosed in the Phase 3 trial of bitopertin for EPP. Results are expected in Q4 2026.
-
Disc Medicine reports Q4 and full year 2025 financial results
Cash position reaches $791 million, providing runway into 2029. Updates on bitopertin Phase 3, DISC-0974, and DISC-3405 trials.
-
Disc Medicine receives FDA Complete Response Letter for bitopertin
FDA acknowledges PPIX reduction evidence but requires Phase 3 APOLLO results for approval. Topline data expected Q4 2026.
Media coverage
-
IRON (Disc Medicine) posts narrower than expected Q4 2025 loss, shares rise slightly in today’s trad...
Our platform provides tax-loss harvesting suggestions and portfolio drift analysis for comprehensive portfolio management. Maintain optimal portfolio allocation with our comprehensive rebalancing ...
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc....
NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ...
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities...
New York, New York--(Newsfile Corp. - April 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities...
-
...Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ:...
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ...
Track Disc Medicine and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Disc Medicine competitors & trending companies
Browse news for competitors to Disc Medicine and other trending companies.
Sobi
Oncopeptides
Kyowa Kirin
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips